ERBB2 and breast cancer: In contrast, treatment of metastatic BC aims to extend life, while maintaining health-related quality of life (HRQoL), typically comprising sequential lines of chemotherapy, which for HER2-positive patients is combined with ongoing HER2-targeted therapy [6].